Skip to main content
. 2018 Jun 7;9(6):692. doi: 10.1038/s41419-018-0727-2

Fig. 2. Echocardiographic properties in control and cardiac-specific Ctsk-CKO mice treated with or without doxorubicin.

Fig. 2

a Representative echocardiographic images; b Wall thickness; c Left ventricular (LV) mass normalized to body weight; d LV end-diastolic diameter; e LV end-systolic diameter; f Fractional shortening. Mean ± SEM, n = 6–8 mice per group. *p < 0.05 vs. Control group, #p < 0.05 vs. Control-Dox group